Aneta Szczerkowska-Dobosz
Overview
Explore the profile of Aneta Szczerkowska-Dobosz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zima K, Purzycka-Bohdan D, Szczerkowska-Dobosz A, Gabig-Ciminska M
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769151
Antigen presentation plays a critical role in the pathogenesis of immune-mediated disorders. This study aimed to investigate the effects of IFN-γ and a cytokine mix (5MIX: IL-1α, IL-17A, IL-22, OsM,...
2.
Brzezinska N, Bulinska B, Zawadzka N, Roter G, Szczerkowska-Dobosz A
Postepy Dermatol Alergol
. 2024 Nov;
41(5):479-486.
PMID: 39606608
Introduction: Acne vulgaris is a highly prevalent skin disorder, driving the ongoing search for innovative treatment modalities. While numerous studies have demonstrated the effectiveness of photodynamic therapy (PDT) in managing...
3.
Rogowska P, Sobjanek M, Szczerkowska-Dobosz A, Nowicki R, Slawinska M
J Cosmet Dermatol
. 2024 Aug;
23(12):4367-4368.
PMID: 39099109
No abstract available.
4.
Czarnecka A, Purzycka-Bohdan D, Zablotna M, Nowicki R, Rebala K, Bohdan M, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540130
Methods: The study enrolled 30 overweight or obese adult patients with chronic plaque psoriasis and 30 overweight or obese volunteers (northern Poland region, Caucasian population). Mood disorders, body mass composition...
5.
Czarnecka A, Zablotna M, Purzycka-Bohdan D, Nowicki R, Szczerkowska-Dobosz A
Medicina (Kaunas)
. 2023 Nov;
59(11).
PMID: 38004054
: Psoriasis is a common, chronic, and immune-mediated inflammatory skin disease recognized to lead to a wide range of comorbid disorders, mainly obesity. The study aimed to evaluate the problem...
6.
Rogowska P, Sobjanek M, Szczerkowska-Dobosz A, Nowicki R, Slawinska M
J Eur Acad Dermatol Venereol
. 2023 Apr;
37(9):e1119-e1120.
PMID: 37114360
No abstract available.
7.
Purzycka-Bohdan D, Nedoszytko B, Sobalska-Kwapis M, Zablotna M, Zmijewski M, Wierzbicka J, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047033
Recent studies have indicated a key role of the impaired suppressive capacity of regulatory T cells (Tregs) in psoriasis (PsO) pathogenesis. However, the genetic background of Treg dysfunctions remains unknown....
8.
Czarnecka A, Purzycka-Bohdan D, Zablotna M, Bohdan M, Nowicki R, Szczerkowska-Dobosz A
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36980866
Psoriasis comorbidities may emerge from pleiotropic mechanisms, including common proinflammatory pathways, cellular mediators or genetic predisposition. Obesity is considered to be an independent risk factor of psoriasis, which may influence...
9.
Purzycka-Bohdan D, Nedoszytko B, Zablotna M, Glen J, Szczerkowska-Dobosz A, Nowicki R
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362116
Psoriasis (PsO) is a chronic, immune-mediated, inflammatory skin disease associated in most cases with pruritus. Chemokines seem to play a significant role in PsO pathogenesis. The aim of the study...
10.
Nedoszytko B, Owczarczyk-Saczonek A, Krasowska D, Szczerkowska-Dobosz A
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361637
Psoriasis is a chronic inflammatory skin disease with many comorbidities resulting from not only local but also systemic inflammation [...].